SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
OrthopedicCosmetic Surgery

PUBLISHER: Grand View Research | PRODUCT CODE: 2152302

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2152302

Thailand Aesthetic Health Market Size, Share & Trends Analysis By Product (Devices, Injectables), By End-use (MedSpas, Aesthetic Surgery Centers), Consumer Behavior, Key Companies, Competitive Analysis, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 3950
Printable PDF & Excel (5-User License)
USD 4950
Printable PDF & Excel (Enterprise License)
USD 6950

Add to Cart

Description

Table of Contents

List of Tables

Thailand Aesthetic Health Market Summary

The Thailand aesthetic health market size was valued at USD 185.7 million in 2025 and is projected to grow from USD 207.6 million in 2026 to USD 451.2 million by 2033, at a CAGR of 11.7% from 2026 to 2033. The market is supported by strong demand for minimally invasive and non-surgical aesthetic procedures, particularly injectables, skin rejuvenation, laser treatments, and body-contouring procedures.

Consumers are increasingly seeking treatments that deliver visible improvements with minimal downtime and can be incorporated into their regular work and social routines. Thailand's established network of aesthetic clinics, dermatology centers, medical spas, and specialized providers gives consumers broad access to these procedures, while the country's reputation for healthcare and beauty services also attracts international patients. The Tourism Authority of Thailand has actively promoted the country as a health and wellness destination, with medical, health, and wellness visitors representing 1.5% of international arrivals and generating an average spending of USD 3,040.6 (THB 100,259) per trip, supporting the wider ecosystem for elective aesthetic services.

Medical and beauty tourism is expected to remain an important growth driver, particularly for premium clinics and facilities offering multiple aesthetic procedures. Thailand's combination of experienced aesthetic practitioners, established private healthcare infrastructure, international connectivity, and tourism services allows international consumers to combine aesthetic treatment with travel and wellness activities. At the same time, domestic demand is supported by growing interest in appearance maintenance, facial aesthetics, skin quality, and minimally invasive procedures.

Recent industry activity demonstrates continued investment in Thailand. For instance, in May 2026, Samyang Biopharm officially launched its polymer-based dermal filler, Lafullen, in Thailand, marking the company's entry into the country's market and introducing another filler option for Thai physicians. Similarly, Galderma opened a Bangkok office in 2026 and announced plans to strengthen its local presence and partnerships with aesthetic clinics, indicating continued investment by major international aesthetics companies in Thailand.

Thailand Aesthetic Health Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Thailand aesthetic health market report based on product, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Device
    • Medical Laser-based Devices
    • Light-based Devices / IPL
    • Radiofrequency (RF)-based Devices
    • Ultrasound-based Devices
    • Microneedling Devices
    • Microdermabrasion Devices
    • Other Aesthetic Devices
  • Injectables
    • Botulinum Toxin
    • Dermal Fillers
    • Hyaluronic Acid - Monophasic
    • Hyaluronic Acid - Biphasic
    • Collagen & PMMA-based Fillers
    • Biostimulators
    • Calcium Hydroxylapatite (CaHA)
    • Poly-L-Lactic Acid (PLLA)
    • Polycaprolactone (PCL)
    • Bioregenerative / Other Injectables
    • PN/PDRN
    • PDRN
    • PN Injectables
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • MedSpas
  • Aesthetic Surgery Centers
  • Hospitals
  • Others
Show more
Product Code: GVR-4-68041-042-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Country scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. End Use Outlook
  • 2.3. Competitive Insights

Chapter 3. Thailand Aesthetic Health Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Thailand Aesthetic Health Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Thailand Aesthetic Health Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Thailand Aesthetic Health Market: Product Movement Analysis
  • 4.3. Thailand Aesthetic Health Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 4.5. Device
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Medical Laser-based Devices
      • 4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Light-based Devices / IPL
      • 4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Radiofrequency (RF)-based Devices
      • 4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Ultrasound-based Devices
      • 4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Microneedling Devices
      • 4.5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.7. Microdermabrasion Devices
      • 4.5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.8. Other Aesthetic Devices
      • 4.5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Injectables
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Botulinum Toxin
    • 4.7.1. Dermal Fillers
      • 4.7.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.1.2. Hyaluronic Acid - Monophasic
        • 4.7.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.1.3. Hyaluronic Acid - Biphasic
        • 4.7.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.1.4. Collagen & PMMA-based Fillers
        • 4.7.1.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Biostimulators
      • 4.7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.2.2. Calcium Hydroxylapatite (CaHA)
        • 4.7.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.2.3. Poly-L-Lactic Acid (PLLA)
        • 4.7.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.2.4. Polycaprolactone (PCL)
        • 4.7.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Bioregenerative / Other Injectables
      • 4.7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7.4. PN/PDRN
      • 4.7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.4.2. PDRN
        • 4.7.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.7.4.3. PN Injectables
        • 4.7.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Thailand Aesthetic Health Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Thailand Aesthetic Health Market: End Use Movement Analysis
  • 5.3. Thailand Aesthetic Health Market by End Use Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033, for the following
  • 5.5. MedSpas
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Aesthetic Surgery Centers
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Hospitals
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Key Company Profiles
    • 6.2.1. Candela Corporation
      • 6.2.1.1. Company Overview
      • 6.2.1.2. Financial Performance
      • 6.2.1.3. Product/Service Benchmarking
      • 6.2.1.4. Strategic Initiatives
    • 6.2.2. Sisram Medical (Alma Lasers)
      • 6.2.2.1. Company Overview
      • 6.2.2.2. Financial Performance
      • 6.2.2.3. Product/Service Benchmarking
      • 6.2.2.4. Strategic Initiatives
    • 6.2.3. Wingderm Electro-optics Ltd.
      • 6.2.3.1. Company Overview
      • 6.2.3.2. Financial Performance
      • 6.2.3.3. Product/Service Benchmarking
      • 6.2.3.4. Strategic Initiatives
    • 6.2.4. WON TECH Co
      • 6.2.4.1. Company Overview
      • 6.2.4.2. Financial Performance
      • 6.2.4.3. Product/Service Benchmarking
      • 6.2.4.4. Strategic Initiatives
    • 6.2.5. Ipsen
      • 6.2.5.1. Company Overview
      • 6.2.5.2. Financial Performance
      • 6.2.5.3. Product/Service Benchmarking
      • 6.2.5.4. Strategic Initiatives
    • 6.2.6. Medytox
      • 6.2.6.1. Company Overview
      • 6.2.6.2. Financial Performance
      • 6.2.6.3. Product/Service Benchmarking
      • 6.2.6.4. Strategic Initiatives
    • 6.2.7. Merz GmbH and Co. KGaA
      • 6.2.7.1. Company Overview
      • 6.2.7.2. Financial Performance
      • 6.2.7.3. Product/Service Benchmarking
      • 6.2.7.4. Strategic Initiatives
    • 6.2.8. Cynosure Lutronic
      • 6.2.8.1. Company Overview
      • 6.2.8.2. Financial Performance
      • 6.2.8.3. Product/Service Benchmarking
      • 6.2.8.4. Strategic Initiatives
    • 6.2.9. Galderma
      • 6.2.9.1. Company Overview
      • 6.2.9.2. Financial Performance
      • 6.2.9.3. Product/Service Benchmarking
      • 6.2.9.4. Strategic Initiatives
    • 6.2.10. Sinclair
      • 6.2.10.1. Company Overview
      • 6.2.10.2. Financial Performance
      • 6.2.10.3. Product/Service Benchmarking
      • 6.2.10.4. Strategic Initiatives
    • 6.2.11. Prollenium Medical Technologies
      • 6.2.11.1. Company Overview
      • 6.2.11.2. Financial Performance
      • 6.2.11.3. Product/Service Benchmarking
      • 6.2.11.4. Strategic Initiatives
    • 6.2.12. Tiger Aesthetics Medical (Suneva Medical, Inc.)
      • 6.2.12.1. Company Overview
      • 6.2.12.2. Financial Performance
      • 6.2.12.3. Product/Service Benchmarking
      • 6.2.12.4. Strategic Initiatives
    • 6.2.13. HUGEL, Inc.
      • 6.2.13.1. Company Overview
      • 6.2.13.2. Financial Performance
      • 6.2.13.3. Product/Service Benchmarking
      • 6.2.13.4. Strategic Initiatives
    • 6.2.14. Teoxane
      • 6.2.14.1. Company Overview
      • 6.2.14.2. Financial Performance
      • 6.2.14.3. Product/Service Benchmarking
      • 6.2.14.4. Strategic Initiatives
Show more
Product Code: GVR-4-68041-042-1

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Thailand aesthetic health market, by product, 2021 - 2033 (USD Million)
  • Table 4 Thailand aesthetic health market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig 1 Thailand aesthetic health market segmentation
  • Fig 2 Market research process
  • Fig 3 Data triangulation techniques
  • Fig 4 Primary research pattern
  • Fig 5 Market research approaches
  • Fig 6 Value-chain-based sizing & forecasting
  • Fig 7 Market formulation & validation
  • Fig 8 Market snapshot
  • Fig 9 Product & emd use outlook (USD Million)
  • Fig 10 Competitive landscape
  • Fig 11 Thailand aesthetic health market dynamics
  • Fig 12 Thailand aesthetic health market: Porter's five forces analysis
  • Fig 13 Thailand aesthetic health market: PESTLE analysis
  • Fig 14 Thailand aesthetic health market: Product segment dashboard
  • Fig 15 Thailand aesthetic health market: Product market share analysis, 2025 & 2033
  • Fig 16 Device market, 2021 - 2033 (USD Million)
  • Fig 17 Medical laser-based devices market, 2021 - 2033 (USD Million)
  • Fig 18 Light-based devices / IPL market, 2021 - 2033 (USD Million)
  • Fig 19 Radiofrequency (RF)-based devices market, 2021 - 2033 (USD Million)
  • Fig 20 Ultrasound-based devices market, 2021 - 2033 (USD Million)
  • Fig 21 Microneedling devices market, 2021 - 2033 (USD Million)
  • Fig 22 Microdermabrasion devices market, 2021 - 2033 (USD Million)
  • Fig 23 Other aesthetic devices market, 2021 - 2033 (USD Million)
  • Fig 24 Injectables market, 2021 - 2033 (USD Million)
  • Fig 25 Botulinum toxin market, 2021 - 2033 (USD Million)
  • Fig 26 Dermal fillers market, 2021 - 2033 (USD Million)
  • Fig 27 Hyaluronic acid - monophasic market, 2021 - 2033 (USD Million)
  • Fig 28 Hyaluronic acid - biphasic market, 2021 - 2033 (USD Million)
  • Fig 29 Collagen & PMMA-based fillers market, 2021 - 2033 (USD Million)
  • Fig 30 Biostimulators market, 2021 - 2033 (USD Million)
  • Fig 31 Calcium hydroxylapatite (CaHA) market, 2021 - 2033 (USD Million)
  • Fig 32 Poly-L-Lactic Acid (PLLA) market, 2021 - 2033 (USD Million)
  • Fig 33 Polycaprolactone (PCL) market, 2021 - 2033 (USD Million)
  • Fig 34 Bioregenerative / other injectables market, 2021 - 2033 (USD Million)
  • Fig 35 PN/PDRN market, 2021 - 2033 (USD Million)
  • Fig 36 PDRN market, 2021 - 2033 (USD Million)
  • Fig 37 PN injectables market, 2021 - 2033 (USD Million)
  • Fig 38 Thailand aesthetic health market: End use segment dashboard
  • Fig 39 Thailand aesthetic health market: Thailand aesthetic health market share analysis, 2025 & 2033
  • Fig 40 Medspas market, 2021 - 2033 (USD Million)
  • Fig 41 Aesthetic surgery centers market, 2021 - 2033 (USD Million)
  • Fig 42 Hospitals market, 2021 - 2033 (USD Million)
  • Fig 43 Others market, 2021 - 2033 (USD Million)
  • Fig 44 Company categorization
  • Fig 45 Company market position analysis
  • Fig 46 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!